• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统评价不同收入环境下获得糖尿病视网膜病变筛查服务的障碍和促进因素。

Systematic review on barriers and enablers for access to diabetic retinopathy screening services in different income settings.

机构信息

Clinical Research Department, Department of Infectious and Tropical Diseases, International Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Clinical Research Department, Department of Infectious and Tropical Diseases, International Centre for Evidence in Disability, London School of Hygiene and Tropical Medicine, London, United Kingdom.

出版信息

PLoS One. 2019 Apr 23;14(4):e0198979. doi: 10.1371/journal.pone.0198979. eCollection 2019.

DOI:10.1371/journal.pone.0198979
PMID:31013274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6478270/
Abstract

BACKGROUND

Diabetic retinopathy (DR) can lead to visual impairment and blindness if not detected and treated in time. Knowing the barriers/enablers in advance in contrasting different country income settings may accelerate development of a successful DR screening (DRS) program. This would be especially applicable in the low-income settings with the rising prevalence of DR.

OBJECTIVES

The aim of this systematic review is to identify and contrast the barriers/enablers to DRS for different contexts using both consumers i.e., people with diabetes (PwDM) and provider perspectives and system level factors in different country income settings.

METHODS

We searched MEDLINE, Embase, CENTRAL in the Cochrane Library from the databases start date to December 2018. We included the studies reported on barriers and enablers to access DRS services based at health care facilities. We categorised and synthesized themes related to the consumers (individuals), providers and the health systems (environment) as main dimensions according to the constructs of social cognitive theory, supported by the quantitative measures i.e., odds ratios as reported by each of the study authors.

MAIN RESULTS

We included 77 studies primarily describing the barriers and enablers. Most of the studies were from high income settings (72.7%, 56/77) and cross sectional in design (76.6%, 59/77). From the perspectives of consumers, lack of knowledge, attitude, awareness and motivation were identified as major barriers. The enablers were fear of blindness, proximity of screening facility, experiences of vision loss and being concerned of eye complications. In providers' perspectives, lack of skilled human resources, training programs, infrastructure of retinal imaging and cost of services were the main barriers. Higher odds of uptake of DRS services was observed when PwDM were provided health education (odds ratio (OR) 4.3) and having knowledge on DR (OR range 1.3-19.7).

CONCLUSION

Knowing the barriers to access DRS is a pre-requisite in development of a successful screening program. The awareness, knowledge and attitude of the consumers, availability of skilled human resources and infrastructure emerged as the major barriers to access to DRS in any income setting.

摘要

背景

如果不能及时发现和治疗,糖尿病视网膜病变(DR)可导致视力损害和失明。在不同国家收入背景下,预先了解DR 筛查(DRS)的障碍/促进因素可能会加速成功的 DRS 项目的发展。这在 DR 患病率不断上升的低收入环境中尤其适用。

目的

本系统综述的目的是从消费者(即糖尿病患者)和提供者的角度,并从系统层面,确定并比较不同国家收入背景下 DRS 的障碍/促进因素。

方法

我们检索了 MEDLINE、Embase 和 Cochrane 图书馆中的 CENTRAL,检索时间从数据库建立开始到 2018 年 12 月。我们纳入了基于医疗机构的 DRS 服务获取障碍和促进因素的研究报告。我们根据社会认知理论的结构,将与消费者(个体)、提供者和卫生系统(环境)相关的主题分类并综合为主要维度,并辅以各研究作者报告的定量指标,如比值比。

主要结果

我们纳入了 77 项主要描述障碍和促进因素的研究。大多数研究来自高收入环境(72.7%,56/77),且设计为横断面研究(76.6%,59/77)。从消费者的角度来看,缺乏知识、态度、意识和动机被认为是主要障碍。促进因素包括对失明的恐惧、筛查设施的便利性、视力丧失的经历和对眼部并发症的担忧。在提供者的角度来看,缺乏熟练的人力资源、培训计划、视网膜成像基础设施和服务成本是主要障碍。当为糖尿病患者提供健康教育(比值比 4.3)和有关 DR 的知识(比值比范围 1.3-19.7)时,DRS 服务的接受度更高。

结论

了解 DRS 的障碍是制定成功筛查计划的前提。在任何收入环境下,消费者的意识、知识和态度、熟练人力资源的可用性以及基础设施都成为 DRS 可及性的主要障碍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/6478270/943654f79c91/pone.0198979.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/6478270/cbe632093011/pone.0198979.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/6478270/50bffabcfe38/pone.0198979.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/6478270/43bfe2b58d58/pone.0198979.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/6478270/caf32e34f6d4/pone.0198979.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/6478270/943654f79c91/pone.0198979.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/6478270/cbe632093011/pone.0198979.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/6478270/50bffabcfe38/pone.0198979.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/6478270/43bfe2b58d58/pone.0198979.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/6478270/caf32e34f6d4/pone.0198979.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/6478270/943654f79c91/pone.0198979.g005.jpg

相似文献

1
Systematic review on barriers and enablers for access to diabetic retinopathy screening services in different income settings.系统评价不同收入环境下获得糖尿病视网膜病变筛查服务的障碍和促进因素。
PLoS One. 2019 Apr 23;14(4):e0198979. doi: 10.1371/journal.pone.0198979. eCollection 2019.
2
Perceived barriers and enablers to the provision of diabetic retinopathy screening for young adults: a cross-sectional survey of healthcare professionals working in the UK National Diabetic Eye Screening Programme.英国国家糖尿病眼病筛查计划中从事医疗保健工作的专业人员对为年轻成年人提供糖尿病视网膜病变筛查的感知障碍和促进因素:横断面调查。
BMJ Open Diabetes Res Care. 2021 Nov;9(2). doi: 10.1136/bmjdrc-2021-002436.
3
Barriers and enablers to diabetic retinopathy screening attendance: Protocol for a systematic review.糖尿病视网膜病变筛查参与的障碍与促进因素:一项系统评价方案
Syst Rev. 2016 Aug 11;5(1):134. doi: 10.1186/s13643-016-0309-2.
4
Understanding the behavioral determinants that predict barriers and enablers of screening and treatment behaviors for diabetic retinopathy among Bangladeshi women: findings from a barrier analysis.理解行为决定因素,预测孟加拉国女性糖尿病视网膜病变筛查和治疗行为的障碍和促进因素:一项障碍分析的结果。
BMC Public Health. 2023 Aug 30;23(1):1667. doi: 10.1186/s12889-023-16106-8.
5
Health system barriers and enablers to early access to breast cancer screening, detection, and diagnosis: a global analysis applied to the MENA region.卫生系统对早期获得乳腺癌筛查、检测和诊断的障碍和促进因素:在中东和北非地区应用的全球分析。
Public Health. 2017 Nov;152:58-74. doi: 10.1016/j.puhe.2017.07.020. Epub 2017 Aug 29.
6
Barriers to and enablers of diabetic retinopathy screening attendance: a systematic review of published and grey literature.糖尿病视网膜病变筛查参与的障碍因素和促进因素:已发表文献和灰色文献的系统评价。
Diabet Med. 2018 Oct;35(10):1308-1319. doi: 10.1111/dme.13686. Epub 2018 Jun 6.
7
A qualitative study on barriers and enablers to uptake of diabetic retinopathy screening by people with diabetes in the Western Province of Sri Lanka.一项关于斯里兰卡西部省份糖尿病患者接受糖尿病视网膜病变筛查的障碍与促进因素的定性研究。
Trop Med Health. 2019 May 17;47:34. doi: 10.1186/s41182-019-0160-y. eCollection 2019.
8
Systematic review and meta-analysis of diagnostic accuracy of detection of any level of diabetic retinopathy using digital retinal imaging.系统评价和 Meta 分析:利用数字视网膜成像检测任何程度糖尿病视网膜病变的诊断准确性。
Syst Rev. 2018 Nov 7;7(1):182. doi: 10.1186/s13643-018-0846-y.
9
Barriers and enablers to diabetic retinopathy screening: a cross-sectional survey of young adults with type 1 and type 2 diabetes in the UK.糖尿病视网膜病变筛查的障碍和促进因素:英国 1 型和 2 型糖尿病青年成年人的横断面调查。
BMJ Open Diabetes Res Care. 2022 Nov;10(6). doi: 10.1136/bmjdrc-2022-002971.
10
Divergent Perceptions of Barriers to Diabetic Retinopathy Screening Among Patients and Care Providers, Los Angeles, California, 2014-2015.2014 - 2015年加利福尼亚州洛杉矶患者与医护人员对糖尿病视网膜病变筛查障碍的不同认知
Prev Chronic Dis. 2016 Oct 6;13:E140. doi: 10.5888/pcd13.160193.

引用本文的文献

1
Identifying facilitators, barriers and areas of opportunity in diabetic retinopathy screening: quality improvement through qualitative methods.识别糖尿病视网膜病变筛查中的促进因素、障碍和机会领域:通过定性方法改进质量
BMJ Open Qual. 2025 Aug 18;14(3):e003310. doi: 10.1136/bmjoq-2025-003310.
2
Development and Validation of a Nomogram-Based Risk Prediction Model for Diabetic Retinopathy in Elderly Adults with Type 2 Diabetes Mellitus.2型糖尿病老年患者糖尿病视网膜病变基于列线图的风险预测模型的开发与验证
Diabetes Metab Syndr Obes. 2025 Jul 25;18:2509-2523. doi: 10.2147/DMSO.S530424. eCollection 2025.
3
Performance of a Retinal Imaging Camera With On-Device Intelligence for Primary Care: Retrospective Study.

本文引用的文献

1
Factors influencing patient adherence with diabetic eye screening in rural communities: A qualitative study.影响农村社区糖尿病眼病筛查患者依从性的因素:一项定性研究。
PLoS One. 2018 Nov 2;13(11):e0206742. doi: 10.1371/journal.pone.0206742. eCollection 2018.
2
Factors associated with participation in a diabetic retinopathy screening program in a rural district in Bangladesh.孟加拉国农村地区参与糖尿病视网膜病变筛查计划的相关因素。
Diabetes Res Clin Pract. 2018 Oct;144:111-117. doi: 10.1016/j.diabres.2018.08.012. Epub 2018 Aug 22.
3
Barriers to and enablers of diabetic retinopathy screening attendance: a systematic review of published and grey literature.
用于初级保健的具有设备内置智能功能的视网膜成像相机的性能:回顾性研究。
JMIR Form Res. 2025 Jul 17;9:e70331. doi: 10.2196/70331.
4
Artificial intelligence versus manual screening for the detection of diabetic retinopathy: a comparative systematic review and meta-analysis.人工智能与人工筛查用于检测糖尿病视网膜病变的比较:一项系统综述与荟萃分析
Front Med (Lausanne). 2025 May 7;12:1519768. doi: 10.3389/fmed.2025.1519768. eCollection 2025.
5
Diabetic Retinopathy (DR): Mechanisms, Current Therapies, and Emerging Strategies.糖尿病视网膜病变(DR):发病机制、当前治疗方法及新兴策略
Cells. 2025 Mar 4;14(5):376. doi: 10.3390/cells14050376.
6
Exploring patient and health care provider perspectives on barriers to diabetic retinopathy screening in public health facilities in North India.探索印度北部公共卫生机构中患者及医疗服务提供者对糖尿病视网膜病变筛查障碍的看法。
Sci Rep. 2025 Mar 10;15(1):8251. doi: 10.1038/s41598-025-92795-y.
7
Impact of teleretinal screening program on diabetic retinopathy screening compliance rates in community health centers: a quasi-experimental study.远程视网膜筛查项目对社区卫生中心糖尿病视网膜病变筛查依从率的影响:一项准实验研究。
BMC Health Serv Res. 2025 Feb 26;25(1):318. doi: 10.1186/s12913-025-12472-8.
8
Intraocular drug delivery systems for Diabetic retinopathy: Current and future prospective.用于糖尿病性视网膜病变的眼内给药系统:现状与未来展望。
Bioimpacts. 2024 May 19;15:30127. doi: 10.34172/bi.30127. eCollection 2025.
9
Barriers and enablers of access to diabetes eye care in Auckland, New Zealand: a qualitative study.新西兰奥克兰地区糖尿病眼部护理可及性的障碍与促进因素:一项定性研究
BMJ Open. 2025 Jan 30;15(1):e087650. doi: 10.1136/bmjopen-2024-087650.
10
Prevalence of diabetic retinopathy and its associated factors among adults in East African countries: A systematic review and meta-analysis.东非国家成年人糖尿病视网膜病变的患病率及其相关因素:一项系统评价和荟萃分析。
PLoS One. 2025 Jan 31;20(1):e0316160. doi: 10.1371/journal.pone.0316160. eCollection 2025.
糖尿病视网膜病变筛查参与的障碍因素和促进因素:已发表文献和灰色文献的系统评价。
Diabet Med. 2018 Oct;35(10):1308-1319. doi: 10.1111/dme.13686. Epub 2018 Jun 6.
4
Awareness of diabetic retinopathy and its association with attendance for systematic screening at the public primary care setting: a cross-sectional study in Hong Kong.香港公立基层医疗环境中糖尿病视网膜病变的知晓情况及其与接受系统筛查的相关性:一项横断面研究
BMJ Open. 2018 Apr 13;8(4):e019989. doi: 10.1136/bmjopen-2017-019989.
5
Behavioral economics and diabetic eye exams.行为经济学与糖尿病眼病检查。
Prev Med. 2018 Jul;112:76-87. doi: 10.1016/j.ypmed.2018.04.006. Epub 2018 Apr 4.
6
Diabetic retinopathy screening in incident diabetes mellitus type 2 in Germany between 2004 and 2013 - A prospective cohort study based on health claims data.2004 年至 2013 年德国新诊断 2 型糖尿病患者的糖尿病视网膜病变筛查——一项基于健康索赔数据的前瞻性队列研究。
PLoS One. 2018 Apr 5;13(4):e0195426. doi: 10.1371/journal.pone.0195426. eCollection 2018.
7
Knowledge, attitude, and practice of diabetic retinopathy among physicians in Northwestern Nigeria.尼日利亚西北部医生对糖尿病视网膜病变的认知、态度及实践
Niger J Clin Pract. 2018 Apr;21(4):478-483. doi: 10.4103/njcp.njcp_266_17.
8
Investigating the Barriers to the Uptake of Diabetic RetinaScreen.探究糖尿病视网膜筛查普及的障碍
Ir Med J. 2017 Oct 10;110(9):628.
9
Diabetic Retinopathy Screening: A Systematic Review on Patients' Non-Attendance.糖尿病视网膜病变筛查:患者不依从性的系统评价。
Int J Environ Res Public Health. 2018 Jan 19;15(1):157. doi: 10.3390/ijerph15010157.
10
Interventions to increase attendance for diabetic retinopathy screening.提高糖尿病视网膜病变筛查参与率的干预措施。
Cochrane Database Syst Rev. 2018 Jan 15;1(1):CD012054. doi: 10.1002/14651858.CD012054.pub2.